Introduction
Nonviral gene delivery systems are presently under development and investigation for the treatment of various inherited and acquired diseases such as cystic fibrosis, hemophilia, and cancer. Cationic polymers such as polyethylenimine (PEI) or poly(N,N-dimethylaminoethyl methacrylate) (P(DMAEMA) have been extensively studied as gene transfer agents in previous studies. 1, 2 These cationic polymers condense plasmid DNA (pDNA) into gene vector nanoparticles 3 due to their high positive charge density and efficiently transfect cells in vitro. However, in vivo application is still limited due to (i) low biocompatibility, (ii) colloidal instability of gene vectors in physiological fluids at high concentrations, and (iii) rapid clearance from the bloodstream after systemic application. 4 Successful gene therapy requires a gene transfer system that efficiently delivers the transgene into the diseased cell, remains colloidally stable at high pDNA concentrations, and avoids inducing adverse effects. P(DMAEMA) was chosen as the polymer lead structure for oligo(ethylene glycol) (OEG) modification because it has been previously shown to fulfill at least two of these requirements, that is, gene transfer efficiency comparable with the "gold standard" branched PEI 25 kDa without causing equally serious toxicity. 5 Moreover, P(DMAEMA) is a water-soluble polymer containing tertiary amino side groups that efficiently condense pDNA into nanoparticles. 2, 6 The polymer was first described in 1996 by Cherng and co-workers. 7 Subsequently, various factors affecting gene transfer efficiency and cytotoxicity were identified, such as (i) molecular weight and molecular weight distribution, 8, 9 (ii) polymer and gene vector composition, such as polymer/pDNA ratio, 8, 9 and (iii) formulation methods, 10 as well as, (iv) transfection parameters such as incubation time and transfection in the absence or presence of serum albumin. 9 Optimum transfection efficiency was found at polymer/pDNA ratios of 3-5/1 (w/w) corresponding to an N/P ratio (which is defined as the ratio between polymeric nitrogen residues and pDNA phosphate groups) of 5-8/1 using high molecular weight polymers (>300 kDa). Under these conditions, small particles of ∼200 nm with a positive surface charge were formed. 7, 9 In addition, a typical bell-shaped relationship between transfection efficiency and polymer/pDNA ratio was observed which was ascribed to ineffective condensation at low polymer/pDNA ratio and cytotoxicity of the polymer with increasing polymer concentrations at high polymer/pDNA ratio, either in its free or complexed form with pDNA. 11 Although cationic polymers exhibit efficient pDNA condensation that leads to efficient cellular uptake of the resulting gene vector particles, their high positive charge density contributes to their high cytotoxicity, which is among the major limiting factors for in vivo application. 12 Although the high number of cationic charges can be partially masked by pDNA condensation, 9 unspecific interactions with blood components, vessel endothelia, and plasma proteins occur upon intravenous injection of cationic gene vectors, which leads to aggregation, activation of the complement system and finally rapid clearance of the gene vectors from the bloodstream. 13, 14 In fact, it has been previously reported that tissue distribution of cationic gene vectors, especially the high transfection efficiency of P(D-MAEMA) or PEI in the lungs, can be ascribed to the formation of aggregates formed with blood cells and plasma proteins after intravenous administration followed by enhanced deposition in the capillary bed of the lungs (physical trapping). 4, [15] [16] [17] On the other hand, a positive charge and a small size are critical for cell surface binding and internalization, which most likely takes place via nonspecific adsorptive endocytosis. 18, 19 Moreover, relatively high concentrations of pDNA are indispensable for in vivo gene vector application. Earlier studies revealed that stable P(DMAEMA)/pDNA particles are formed up to a concentration of 40 µg/mL at physiological pH, however, at pDNA concentration > 40 µg/mL aggregation occurred. It has been reported that lowering the pH of the solution can enhance charge density of P(DMAEMA) and condensation properties, hence, increasing colloidal stability. 20 Indeed, concentrated gene vector suspensions with pDNA concentrations up to 200 µg/mL can be formed only under nonphysiological pH (pH 5.7) in the presence of 20% sucrose and at low ionic strength. 10 The aforementioned problems emphasize the need for the design of novel gene transfer agents to encounter these limitations. A common approach to efficiently shield the positive surface charge of the gene vectors takes advantage of introduction of hydrophilic, noncondensing moieties such as poly(ethylene glycol) (PEG), 21 N-vinyl-pyrrolidone (NVP), 9 and poly[N-(2-hydroxypropyl) methacrylamide] (HPMC) 22 into the cationic polymer scaffold. This so-called "PEGylation" of cationic polymers such as PEI, poly-L-lysin (PLL) and P(DMAEMA) led to block [23] [24] [25] [26] [27] or graft copolymers, 18, 28, 29 as well as, postPEGylated gene vector particles 17, [30] [31] [32] and ternary PEGmodified gene vector complexes. 30 PEGylation resulted in (i) reduction of cytotoxicity in vitro and in vivo, (ii) improved water solubility and colloidal particle stability, (iii) decreased chargedependent interactions with plasma proteins or circulating cells, and (iv) increased circulation time in the bloodstream. Finally, PEG-graftment has been successfully used as a spacer moiety between a targeting ligand and a cationic polymer. 21 Moreover, a phase I clinical trial using PEGylated PLL/pDNA complexes has been conducted in cystic fibrosis (CF) patients with some success in partial correction of the CF chloride transport defect, while no inflammatory response or other toxicity due to the gene vector was observed. 33 Nevertheless, an ideal nonviral gene transfer agent has not been identified up to now. Gene delivery using P(DMAEMA)-based gene vectors is a complex process and PEGylation may largely affect their physiochemical and biological activity but these processes have not been addressed in detail as has previously investigated for PEI-based gene vectors. 23 Welldefined block copolymers based on polymethacrylates are currently in the focus for being applied in nonviral gene delivery. 34, 35 Our study aimed at providing a series of welldefined P(DMAEMA-co-OEGMA) copolymers with increasing OEG ratios and molecular weight via atom transfer radical polymerization (ATRP). This controlled radical polymerization technique allows synthesis of well-defined copolymers with predictable molecular weight, narrow molecular weight distribution, and controlled composition to address as accurately as possible known molecular weight requirements. 8 In particular, influence of the macromolecular structure of the OEGMA copolymers (especially the influence of the OEG block) on their ability to condense pDNA and the physiochemical properties of the resulting gene vector particles were investigated in detail. In a second step, physiochemical properties were investigated in the context of the transfection efficiency of the gene vectors in vitro. Branched polyethylenimine (br-PEI), which is still the "gold-standard" cationic polymer, was used for comparison. 1 The tube was sealed with a rubber septum and subsequently purged with dry argon for 20 min. Then, a degassed mixture of OEGMA (120 -n equiv), DMAEMA (n equiv), and ethanol (monomers/solvent ∼ 1:1.25 v/v) were added through the septum with a degassed syringe. Finally, the initiator methyl 2-bromopropionate (1 equiv) was added through the septum with the help of a microliter syringe. The mixture was transferred into a thermostatted oil bath and was heated at 60°C for 8 h. The experiment was stopped by opening the tube and exposing the catalyst to air. At this stage, the raw polymerization mixture was analyzed by 1 H NMR in CDCl 3 . Monomer conversions were calculated from the NMR spectrum by comparing the integrations of the vinyl protons of the remaining monomers (5.50 and 6.05 ppm) to the overall integration of the region 3.85-4.40 ppm, where resonates two protons of the remaining monomers and two protons of the formed polymers. The raw polymerization mixture was diluted with ethanol and passed through a short silica column (60-200 mesh) to remove the copper catalyst. Then, the filtered solution was diluted with deionized water and subsequently purified by dialysis in water (Roth, ZelluTrans membrane, molecular weight cutoff: 4000-6000). Last, water was removed by rotary evaporation. The formed copolymers P(DMAEMAco-OEGMA) appeared as yellowish oils and were characterized by size exclusion chromatography (SEC) and 1 H NMR. Molecular weights and molecular weight distributions were measured by SEC performed either at 25°C in tetrahydrofuran (THF) or at 70°C in N-methylpyrollidone (NMP; flow rate was 1 mL · min -1 in all cases). For calibration, linear polystyrene standards (PSS Germany) were used. The comonomer composition (e.g., the molar fraction of OEGMA in the copolymer F OEGMA ) of the formed copolymers was determined by NMR by comparing the integration of specific protons of the OEGMA monomer units with those of DMAEMA units. For example, one approach is to compare the integration of the methoxy protons of the OEGMA units (3.35 ppm) to the overall integration of the region 3.85-4.35 ppm, where resonates two protons of the OEGMA units and two protons of the DMAEMA units. For these copolymers, we selected the following nomenclature: P(DMAEMA n -co-OEGMA(X) m ), where X represents the number of EG units of the OEGMA monomer (X ) 9, 23, and 45 EG units). The indexes n and m denote the average number of DMAEMA and OEGMA monomers per P(DMAEMA-co-OEGMA) copolymer, respectively.
Preparation of Polymer-Plasmid DNA Complexes. Stock solutions of P(DMAEMA)-co-OEGMA copolymer series were prepared in double distilled water. For transfection experiments, pDNA and polymer stock solutions were diluted separately in 25 µL of Hepes Buffered Saline (HBS, 150 mM NaCl, 10 mM Hepes, pH 7.4). Plasmid DNA solution was added to the polymer solution and mixed gently by pipetting up and down 5-8 times, resulting in different N/P ratios (defined as the ratio between polymeric nitrogen residues and DNA phosphate groups) with a final pDNA concentration of 20 µg pDNA per mL. Subsequently, gene transfer complexes were incubated for 20 min at room temperature prior to further use.
Size and Zeta Potential Measurements. Particle size (determined by dynamic light scattering DLS) and zeta potential of the polymer-pDNA complexes were measured using a Zeta Potential Analyzer with a solid state laser operating at 30 mW (Brookhaven Instruments Corporation, Vienna, Austria). Complexes were prepared in double-distilled water at a N/P ratio of 20:1, as described above. Plasmid DNA concentration was fixed at 20 µg/mL. Complexes were incubated for 20 min before measurement. Measurements were performed at 25°C using the following settings: 5 subruns (particle size) and 10 subruns (zeta potential); the viscosity (0.89 cP); refractive index (1.333) of water; and beam mode F(Ka) ) 1.50 (Smoluchowsky). The instrument was calibrated using polystyrene latex suspension with a well-defined mean diameter of 92 ( 3.7 nm (Duke Scientific Cooperation, CA) for size and Bl-LC-ZRZ reference of -50 ( 5 mV (Laborchemie, Vienna, Austria) for zeta potential measurements. Results are given as mean hydrodynamic diameter (nm) ( standard error (intensity distribution) or zeta potential (mV) ( standard error. In addition, the homogeneity of the particle sizes is expressed by the polydispersity index (PI), which ranges from smaller than 0.2 for a homogeneous up to 1.0 for a heterogeneous size distribution.
To study the influence of salt concentration on particle stability (colloidal stability assay), a 10-fold concentrated HBS solution was used to adjust the required salt concentration. Subsequently, particles size was analyzed every 5 min at 25°C using the following settings: 10 subrun measurements per sample; the viscosity of HBS (1.44 cPa), refractive index (1.333).
Agarose Gel Retardation Assay. The extent of DNA binding and condensation by the novel copolymers were investigated by electrophoresis on agarose gel. Briefly, polyplexes were formed at varying N/P ratios in HBS as described above (see Preparation of Polymer-Plasmid DNA Complexes), mixed with 6× loading buffer (0.25% bromphenol blue, 0.25% xylene cyanol FF, 30% glycerol in water), applied in the slots of a 0.8% agarose gel, and run at 120 V for 1.5 h. The amount of unbound pDNA in agarose gel electrophoresis was analyzed with AIDA Image Analyzer Software (Raytest, Straubenhardt, Germany). Band intensity of free sc pDNA was set as 100% unbound pDNA.
Fluorescence Quenching Assay. Plasmid DNA was labeled with the bisintercalating dye TOTO-1 iodide (1 molecule of TOTO-1 per 20 base pairs of the nucleotide). 36 Plasmid DNA/polymer complexes were formed by adding equal volumes of TOTO-1 labeled pDNA (0.25 µg/ 50 µL solvent in each well) to the polymer solution (final N/P ratio of 20) in 96-well plates and incubating for 20 min at room temperature. Fluorescence intensity of TOTO-1 was measured at 25°C on a Wallac Victor 2 /1420 Multilabel Counter (Perkin-Elmer, Rodgau-Juegesheim, Germany) using an excitation wavelength (λ ex ) of 485 nm and an emission wavelength (λ em ) of 535 nm. The fluorescence intensity was measured for HBS background (F back ), TOTO-1 labeled pDNA (F DNA ), and gene vectors containing TOTO-1 labeled pDNA (F pol ) at 25°C. Triplicates were used for each measurement. The percentage of quenching was calculated as follows:
Negative Staining of Polymer-pDNA Complexes. For electron microscopy analysis, complexes were formed at an N/P ratio of 20 in HBS with a final pDNA concentrations of 20 µg/mL (see above). Samples were prepared freshly and incubated at room temperature for 20 min prior to the preparation of electron microscopy specimens. To this end, about 25 µL of the samples were filled into wells of a Polyoximethylen black plastic block and particles were adsorbed for 90 s onto a 3 × 3 mm piece of carbon film. The carbon film was then transferred to a second well filled with 2% aqueous uranyl format solution for 2 min and was picked up from the staining solution by putting a cooper grid covered with a holey carbon film on top of the floating carbon film. 37 After blotting the excess liquid, the grid was dried and stored at room temperature. Specimens were imaged using a CM200 FEG electron microscope (Philips/FEI, Eindhoven, Netherlands). Images were taken at room temperature on a 4k 4k chargecoupled device (CCD) camera (TVIPS, Gauting, Germany) with 2-fold pixel-coarsening. Particle dimensions were determined using the software EMMENU of TVIPS.
Native Cryo Preparation of Vitrified Specimens. Identical samples of the pDNA-polymer complexes in HBS used for negative staining electron microscopy were also subjected to vitrification for native cryo electron microscopy without staining. A total of 5 µL of the samples were pipetted onto a glow-discharged electron microscopic grid covered with a holey carbon film. After briefly blotting the excess liquid, the grid was rapidly freeze-plunged into liquid ethane and stored in liquid nitrogen until imaging. 38 Images were taken at liquid nitrogen conditions using a CM200 FEG electron microscope equipped with a Gatan cryoholder (Gatan GmbH, Munich, Germany). For electron microscopical analysis, a CCD camera (TVIPS) was used and particle dimensions were determined using the EMMENU software.
Determination of Metabolic Cytotoxicity. Cytotoxicity of P(D-MAEMA) and P(DMAEMA-co-OEGMA) polymers was analyzed in 96-well plates on BEAS-2B cells. Cells were seeded with a density of 20000 cells per well in quadruples into 96-well plates. Different polymer concentrations (16-500 µg/µL) dissolved in MEM + 10% FCS were added to the cells. After 24 h of incubation (37°C, in a humidified 5% CO 2 -containing atmosphere), the number of viable cells was analyzed using a PerkinElmer ATPlite Luminescence Detection Assay System (PerkinElmer, Boston, MA) according to the manufacturer's instructions. Untreated cells were used as a reference by setting the corresponding luminescence to 100% viable cells.
Transfection Experiments and Luciferase Activity Measurements. For transfection, 20000 and 100000 cells were seeded 24 h before transfection in each well of a 96-and 24-well plate, respectively (TPP, Trasadingen, Switzerland). Cells were rinsed with PBS (Gibco-BRL, Karlsruhe, Germany) immediately before transfection. A total of 200 µL of fresh serum-free medium were added per well and, subsequently, 50 µL of the gene vector complexes prepared as described above corresponding to 0.25 µg and 1 µg of pDNA per 96 and 24 wells, respectively, were added. After 4 h of incubation at 37°C in a humidified 5% CO 2 -containing atmosphere, the transfection medium was replaced with MEM, including 10% FCS supplemented with 0.1% (v/v) penicillin/streptomycin and 0.5% (v/v) gentamycin (Gibco-BRL, Karlsruhe, Germany). A total of 24 h post-transfection, luciferase activity was measured in relative light units (RLU) using a Wallac Victor 2 1420 Multilabel Counter (Perkin-Elmer, Boston, MA) according to Huth et al. 39 Results were normalized to total cell protein using the BioRad Protein Assay (BioRad, Munich, Germany) and bovine serum albumin as protein standard.
Flow Cytometry Analysis. Flow cytometry analysis was used to distinguish between associated and internalized fluorescently labeled polymer-pDNA complexes in BEAS-2B cells. Flow cytometry has been previously used to distinguish between surface associated and internalized gene vector particles. The percentage of fluorescent cells and their mean fluorescence intensity were determined using a FACScan flow cytometer (Becton Dickinson, San Jose, CA) equipped with a 488 nm air-cooled argon ion laser. The viable cells were further differentiated from nonviable ones by staining with propidium iodide (PI, Molecular Probes, Leiden, Netherlands). A minimum of 2000 cells was measured in each sample using forward scatter, side scatter, and filter settings for emission at 530 ( 30 nm (FL1) to detect TOTO-1 labeled pDNA and 585 ( 42 nm (FL2) to detect propidium iodide positive cells.
A useful, fast, and reliable method has been described by Hed et al. 40 For this purpose, gene vector pDNA was fluorescence-labeled with the bisintercalating dye TOTO-1 before transfection and gene vectors were formed as described previously and added to BEAS-2B cells for 1 h at 37°C as described for transfection. Before analysis, cells were rinsed with PBS and dislodged from the wells by 8 min incubation with 100 µL of trypsin, 0.05% (1×) with EDTA (Gibco-Invitrogen, Karlsruhe, Germany) at 37°C to generate single-cell suspensions. The cells were collected in a tube and stored on ice prior to flow cytometric analysis. After addition of cell impermeable TOTO-1 fluorescence quenching reagents such as crystal violet 40 or trypan blue, 41, 42 the ratio of cell surface bound to internalized gene vectors can be estimated. These reagents cause quenching of cell surface attached TOTO-1 gene vector fluorescence only without affecting the fluorescence intensity of internalized gene vector complexes. Hence, this method allows to distinguish between the ratio of cell surface associated and internalized gene vector complexes. Trypan blue added to cells incubated with TOTO-1 labeled P(DMAEMA) gene vector complexes at a concentration > 0.15 mg/mL at pH 5 and 7.4 resulted in a plateau of fluorescence positive cells with comparable mean fluorescence intensities (20 and 39% reduction of fluorescence positive cells and mean fluorescence intensity, respectively), indicating successful quenching of cell surface attached gene vectors only but not internalized gene vectors. No significant difference was observed for pH 5 and 7.4, although it was reported that fluorescence quenching using trypan blue works better at lower pH. 41 Thus, the following experiments were all performed at pH 7.4.
Another method to distinguish between adherent and internalized gene vector complexes has been described previously. 43 Fluorescencelabeled gene vector particles that are attached to the cell surface via electrostatic interactions can be efficiently removed using CellScrub washing buffer (GeneTherapy Systems, San Diego, CA) for 15 min at room temperature according to the manufacturer's instructions. Thus, this approach allows to discriminate between extracellularly bound and internalized complexes. 44, 45 Indeed, the number of fluorescence positive cells decreased 20% after additional incubation of CellsScrub washing buffer (cellular internalization) compared to the number of fluorescence positive cells after washing with PBS (cellular association) alone. Similar observations were made for the mean fluorescence intensity with a decrease of 32%. These observations indicated that this procedure allowed to remove cell surface bound gene vectors.
In Vivo Application. Gene vectors were generated as follows: plasmid DNA (pCpGLuc) and brPEI 25 kDa or P[DMAEMA 80 -co-OEGMA (9) 40 ] copolymer were each diluted in 0.4 mL of HBS (HBS, 150 mM NaCl, 10 mM Hepes, pH 7.4). Plasmid DNA solution was added to the polymer solution and mixed gently by pipetting up and down 5-8 times, resulting in a final pDNA concentration of 12.5 µg pDNA per 50 µL and NP ratio of 10 and 20 for brPEI and P[DMAEMA 80 -co-OEGMA (9) 40 ] copolymer, respectively. Subsequently, gene transfer complexes were incubated for 20 min at room temperature prior to further use. The complexes were applied to Balb/C mice (n ) 5) via an intratracheal administration route as described by Bivas-Benita et al. 46 Mice were anesthesized with a mixture of medetomdiine (11.5 µg/kg), midazolam (115 µg/kg), and fentanyl (1.15 µg/kg) and suspended on a plate system (Hallowell EMC) at a 45°a ngle by the upper teeth. A modified cold-light otoscope Beta 200 (Heine Optotechnik) was used to provide optimal illumination of the trachea, while a small spatula helped to open the lower jaw of the mouse and blunted forceps were used to displace the tongue for maximal oropharyngeal exposure. Subsequently, the tip of a Microsprayer Aerosolizer (Model 1A-1C and Aerosolizer FMJ-250, PennCenturyInc., Philadelphia, PA) was intratracheally inserted to apply 50 µL of complexes, corresponding to 12.5 µg plasmid DNA, to each mouse. The tip was withdrawn after 5 s and, subsequently, the mouse was taken off the support after 5 min. Mice were again anaesthetized as described above after 24 h, and afterward, the mice were given intraperitoneal injections of D-luciferin substrate dissolved in water and adjusted to pH 7 (3 mg in 100 µL/mouse). After 10 min, bioluminescence was measured (IVIS 100 imaging system; Xenogen, Alameda, CA) using the following camera settings: field of view 10, f1 f-stop, high resolution binning, and exposure time of 10 min. The signal in the lung region was analyzed using Living Image Software version 2.50 (Xeniogen; Alameda, CA) and background subtracted.
Results and Discussion
Synthesis and Characterization of P(DMAEMA-co-OEGMA) Copolymers. Tailor-made copolymers of OEGMA and DMAEMA were prepared by atom transfer radical polymerization. 47, 48 The role of the DMAEMA units in these copolymers is to form a complex with the negatively charged backbone of DNA. The role of the OEGMA units is to stabilize the formed polyplexes in aqueous medium and moreover to prevent immunological responses that might lead to an active removal of the polyplexes in vivo. Three different series of copolymers were prepared and characterized (Table 1) . In these series, two main parameters were varied: (i) the chain-length of the OEG side chains (i.e., 9, 23, or 45 EG units) and (ii) the comonomer composition of the copolymers (i.e., the copolymers have a theoretical chain length of 120 in all cases, but have a variable DMAEMA/OEGMA composition). The objective of these comprehensive series is to identify the influence of the copolymer structure on the biological behavior of the gene carriers.
All copolymers were synthesized using methyl 2-bromopropionate (MBP) as an initiator and a combination of copper(I) bromide and 2,2′-bipyridyl as catalyst. The copolymerizations were performed in ethanol solutions at 60°C. We recently reported that such conditions are ideal for preparing watersoluble polymers in a relatively short time. 49, 50 In all cases, copolymers P(DMAEMA-co-OEGMA) were isolated in high yields. Table 1 shows the properties of the synthesized polymers. ATRP allowed synthesis of relatively well-defined copolymers with controlled molecular weight and composition. Experimental molecular weights measured by SEC were in most cases relatively close to theoretical values. Still, for very long OEGMA side chains (e.g., 23 or 45 EG units), SEC molecular weights were found to be underestimated. This behavior is typical of copolymers with a high OEGMA content and is due to the strong differences in hydrodynamic volume between the studied polymers and the linear PS standards used for SEC calibration. 49, 51 Furthermore, in all cases, the experimental compositions were found to be close to the theoretical values (i.e., the initial composition OEGMA/DMAEMA in the initial comonomer feed). These results are indeed a direct consequence of the high monomer conversions reached in all experiments in the presence of the copper(I) bromide/2,2′-bipyridyl catalyst. On the other hand, this catalyst combination led in some cases to relatively broad molecular weight distributions. This situation can be improved with the use of a copper(I) chloride-based ATRP catalyst. 49 Nevertheless, the control over chain polydispersity is not a parameter of crucial importance for the present study.
Complexation of pDNA with P(DMAEMA-co-OEGMA) Copolymers. The capacity of br-PEI, P(DMAEMA), and P(D-MAEMA-co-OEGMA) copolymers to complex pDNA was studied by agarose gel retardation assay (Supporting Information, Figure 1A ,B). The amount of free noncomplexed pDNA was calculated from DNA band intensities of unbound and complexed pDNA, respectively ( Figure 1A,B) . No free pDNA was observed for br-PEI and P(DMAEMA) at all N/P ratios tested indicating complete pDNA complexation (Supporting Information, Figure 1B ). Plasmid DNA complexation by P(DMAEMAco-OEGMA) copolymers with low F OEGMA (e50%) increased with increasing N/P ratios and decreased with increasing OEGMA molar ratio (F OEGMA ) and molecular weight (EG units; Figure 1 . Agarose gel electrophoresis of P(DMAEMA-co-OEGMA) copolymers gene vector complexes at different N/P ratios. Quantitative analysis of unbound pDNA as a function of (A) F OEGMA (9 EO units) (B) and ethylene oxide units/OEGMA (F OEGMA ) 25%). The amount of unbound pDNA in agarose gel electrophoresis was analyzed with AIDA Image Analyzer Software. Band intensity of free sc pDNA was set as 100% unbound pDNA. The graph shows pDNA binding and condensation properties at different N/P ratios. Figure 1A ,B). At high F OEGMA (>50%) pDNA complexation was abolished and free pDNA was present in the agarose gel for all N/P ratios tested (Supporting Information, Figure 1A, lanes  1-8) . Only at low F OEGMA (16.7%) and low OEGMA molecular weight (EG units < 9) pDNA migration was completely retarded (indicating complete DNA complexation) as observed for P(DMAEMA). In general, complexation of pDNA decreased with increasing F OEGMA and OEGMA chain length.
Further, interaction of P(DMAEMA), br-PEI, and P(D-MAEMA-co-OEGMA) copolymers with pDNA was analyzed by fluorescence quenching assay ( Table 2 ). The fluorescent bisintercalator TOTO-1 was used to monitor the formation of complexes in the presence of the cationic polymers. The quenching of the strong fluorescence signal can be taken as a measure for complex formation and vice versa the recovery of the fluorescence as an indication for complex disassembly. Branched PEI induced strong pDNA condensation, which was evident by a decrease of the initial TOTO-1-pDNA fluorescence intensity up to 86%. In contrast, pDNA condensation was only moderate for P(DMAEMA) and further reduced for P(D-MAEMA-co-OEGMA) copolymers.
Agarose gel retardation and quenching assay demonstrated that reduction of the positive charge density of P(DMAEMA) together with introduction of sterically bulky OEGMA copolymers in the p(DMAEMA) scaffold reduced polymer binding to the negatively charged pDNA phosphate groups. These observations are in agreement with studies by Verbaan and colleagues, who observed that copolymers with a high degree of PEGgrafting (i.e., PEG > 22%) were not capable of binding to pDNA. 52 It has been argued that pDNA condensation is compromised in the presence of PEG moieties, which may adversely affect or even prevent interaction between the cationic block and pDNA due to an unfavorable entropy change. 53 Different studies of P(DMAEMA)-based copolymers with varying hydrophobic/hydrophilic character further indicated that condensation of pDNA by cationic polymers is a cooperative process in which ionic and other types of interactions such as hydrogen bonding or hydrophobic interactions might be important.
9,54
Size, Surface Charge, and Morphology of the P(D-MAEMA-co-OEGMA) Gene Vectors. Particle size and surface charge of gene vectors are major determinants for transfection efficiency in vitro. [7] [8] [9] 55 It has previously been reported that negatively charged and large-sized P(DMAEMA)-pDNA gene vectors yielded only low transfection efficiency, whereas high transfection rates were observed for positively charged gene vectors of 150 nm diameter. Therefore, the influence of OEGMA-copolymerization on particle characteristics such as zeta potential and particle size together with colloidal stability was evaluated.
Size measurements using dynamic light scattering revealed that P(DMAEMA-co-OEGMA) copolymers form nanoparticles with pDNA with a narrow size distribution (PI ) 0.167 ( 0.085 -0.334 ( 0.063), except for P(DMAEMA 90 -co-OEGMA(9) 30 ), which showed a high PI ) 0.677 ( 0.241. The particle size of the P(DMAEMA-co-OEGMA) gene vectors increased in a direct proportion to increasing F OEGMA > 20% (Figure 2A ) and OEGMA chain-length ( Figure 2B ). P(DMAEMA-co-OEGMA) gene vectors were smaller in size than p(DMAEMA) gene vector complexes (Figure 2A) . The correlation between F OEGMA and OEGMA chain length with P(DMAEMA-co-OEGMA) gene vectors size may be related to the fact that, with an increasing degree of OEGMA copolymerization and OEGMA chain-length, complexation of pDNA is altered and therefore gene vectors lose their spherical shape. 23 Apparently, low degrees of OEGMA copolymerization did not prevent pDNA condensation, which is in agreement with the results from the agarose gel retardation assay. a Plasmid pDNA labeled with the bisintercalating dye TOTO-1 at a basepair-to-dye ratio 20:1 were complexed with P(DMAEMA-co-OEGMA) copolymers at an N/P ratio 20. Fluorescence intensity was measured in quadruble samples. The results represent the reduction in fluorescence intensity of pDNA condensed by the polymers compared to pDNA alone (% quenching). This ratio is a measure for the pDNA condensing properties of the polymers. The surface charge of P(DMAEMA-co-OEGMA) gene vectors gradually decreased with increasing F OEGMA and/or OEGMA molecular weight. This observation likely reflects the "shielding effect" of the OEGMA segments of the P(DMAEMA-co-OEGMA) copolymers. In the case of the P(DMAEMA) gene vectors, zeta potentials of ∼25 mV were measured, indicating a high positive surface charge of the gene vectors (Figure 2A) . Similar values have been previously reported by others. 7, 9, 10 Moreover, the above-mentioned shielding effect of the OEGMA segments correlated with F OEGMA , resulting in gene vectors with lower surface charge close to the isoelectric point with F OEGMA > 50% (Figure 2) . Thus, it seems likely that the P(DMAEMAco-OEGMA) copolymers form core-shell structures with OEG units orientated toward the complex surface, thereby shielding the cationic net charge of the gene vectors. In agreement with this observation, high OEGMA molecular weight (i.e., OEGMA with higher number of EG units) led to even negatively charged particles ( Figure 2B ). Such negative surface charge possibly results from loosely packed gene vectors with residual noncomplexed pDNA present at the nanoparticle surface. Because the zeta potential measurements were carried at low ionic strength, the surface charge of the particles under conditions used for transfection experiments was apparently lower than the values shown in Figure 2 . Thus, the data should not be considered in absolute values but only as indications for the net particle charge.
Further, gene vectors derived from P(DMAEMA-co-OEG-MA) copolymers were found to be kinetically stable under isotonic saline conditions. No increase in particles size was observed within 30 min after formation presumably due to steric stabilization by the multiple-uncharged hydrophilic OEGMA segments within the polymer scaffold (Supporting Information, Figure 2 ). Even low molecular weight OEGMA segments were sufficient to provide stabilization of the gene vectors. Under identical conditions, complexes prepared with P(DMAEMA) resulted in large aggregates of approximately 600 nm, which continuously grew in size. These findings are in accordance with results previously published in literature and confirm the importance of nonelectrostatic shielding components within the cationic polymer to form compact stable gene vector particles. Even at high initial pDNA concentrations of up to 1 mg/mL, P(DMAEMA-co-OEGMA) copolymer derived gene vectors remained kinetically stable (data not shown) without precipitation, whereas nonaggregated P(DMAEMA) gene vector complexes of up to 200 µg pDNA/mL were observed only at low nonphysiological pH. 10 In summary, surface charge and particle diameter could be controlled by varying both the OEGMA molecular weight and F OEGMA . Colloidal stability of P(DMAEMA-co-OEGMA) gene vectors is presumably a result of steric stabilization by OEG units 13 and only to lesser extent because of remaining segments of positively charged polymer groups that were not involved in pDNA binding but may act as a repulsive barrier to prevent aggregation. 20, 56 Further, we studied the influence of P(DMAEMA-co-OEGMA) copolymer composition on morphology of the gene vectors using electron microscopy to confirm our suggestions made from particle size and surface charge measurements. The homopolymer P(DMAEMA) showed compact globular particles of approximately 600 nm in diameter ( Figure 3A,E) . These observations are consistent with size measurements by dynamic light scattering (∼600 nm). OEGMA-copolymerisation significantly reduced the diameter of the gene vectors to 100-200 nm ( Figure 3E ). Increasing F OEGMA resulted in gradual loss of the compact, globular gene vector shape, and appearance of filamentous structures which can be attributed to reduced pDNA condensation and is in agreement with an increase in gene vector size. P(DMAEMA-co-OEGMA) copolymers with low F OEGMA , showed both compact pDNA complexes of globular shape ( Figure 3B ) and associated poorly or noncondensed pDNA, whereas copolymers with high F OEGMA exhibited predominately shapeless structures of assembled pDNA (Figure 3C,D) .
Evaluation of Cytotoxicity. Like for other cationic polymers, the use of P(DMAEMA) and br-PEI as gene transfer agents has been reported to be limited by their cell toxicity even at low concentrations. 9, 57 Cytotoxicity has been reported to be predominantly a result of the positive polymer charge, 7-9 which can be only partially masked by complexation of the cationic polymer with pDNA.
9,58 Nevertheless, gene therapy requires efficient gene delivery systems without induction of any adverse effects. It was therefore expected that increasing F OEGMA should yield a decrease of cationic charge density and, thus, lead to a decrease of P(DMAEMA-co-OEGMA) cytotoxicity. Cytotoxicity of free P(DMAEMA), br-PEI, and P(DMAEMA-co-OEGMA) copolymers was investigated on human bronchial epithelial cells ( Supporting Information, Figure 3 ). Whereas P(DMAEMA) and the "gold standard" br-PEI 25 kDa resulted in higher toxicity (0.8% and 3.7% cell viability at the highest concentration tested), none of the P(DMAEMA-co-OEGMA) copolymers tested were cytotoxic, even at high polymer concentrations independently of the degree of grafting (F OEGMA ) and OEGMA molecular weight (Supporting Information, Figure 3 ).
Transfection Efficiency of P(DMAEMA-co-OEGMA) Gene Vectors In Vitro. Transfection efficiency of P(D-MAEMA-co-OEGMA) copolymers was analyzed in comparison to P(DMAEMA) and br-PEI in vitro on human bronchial epithelial cells. Transfection efficiency of P(DMAEMA) gene vectors was highest at N/P ) 20 but 10-fold lower compared with br-PEI gene vector complexes at N/P ) 10 ( Figure 4A ). These observations were in agreement with previously published results. 8, 59 Transfection efficiency of P(DMAEMA-co-OEGMA) copolymer gene vectors was dependent on the N/P ratio and decreased gradually with increasing F OEGMA ( Figure 4A ). In agreement with the results from pDNA binding, high N/P ratios (in the range of 10-40) were necessary to achieve high transfection levels. Although OEGMA copolymerization reduced transfection efficiency of P(DMAEMA-co-OEGMA) copolymer gene vectors, similar transfection rates as those observed for P(DMAEMA) were achieved with low F OEGMA and OEGMA molecular weight at N/P ratios of 10-40 (F OEGMA e 33.3%; EG units ) 9).
To consider the variability of transfection activity between different cell types and assess the influence of F OEGMA and OEGMA molecular weight on another cell line, transfection studies were further carried out on murine alveolar epithelial cells at N/P ratios of 10 and 20 ( Figure 4B ). Similar results were found in both cell lines. Transfection efficiency of P(DMAEMA-co-OEGMA) copolymer gene vectors was dependent on the N/P ratio, F OEGMA and OEGMA molecular weight, respectively, but independent of the cell line tested. Only low transfection levels were observed for OEGMA-rich copolymers (F OEGMA > 25%) at a N/P ratio of 10 and 20 in both cell lines (Figure 4 B) . Furthermore, at similar F OEGMA , gene transfer efficiency of P(DMAEMA-co-OEGMA) copolymers decreased with increasing OEGMA molecular weight ( Figure  4C ). Low transfection efficiencies observed for P(DMAEMAco-OEGMA) copolymers with high F OEGMA compared with P(DMAEMA-co-OEGMA) copolymers with low F OEGMA may not be a result of differences in particle size that were found to be within the same range. The decrease in transfection efficiency may be accounted by the less compact particle structure and completely shielded particle surface charge at high F OEGMA . It has been reported that particle shielding reduces attachment of the gene vector complex to the cell surface. 18, 23, 52, 60 Obviously, gene vector shielding counteracts interactions with cell surfaceassociated proteoglycans which have been previously demonstrated to be involved in initializing cellular gene vector uptake. In addition, a decrease in the number of tertiary amine groups resulted in weakening of pDNA binding. Thus, poor gene expression observed from P(DMAEMA-co-OEGMA) copolymers with high F OEGMA (F OEGMA > 25%, EO units > 9) may further be caused by dissociation of pDNA from the cationic polymer in serum-free media before cell internalization. Nevertheless, transfection levels similar to that of the P(DMAEMA) and approximately 10-fold less than that of br-PEI could be achieved with P(DMAEMA-co-OEGMA) composed of 16.66% OEGMA and 9 EG units in the OEGMA segment. Cellular Association and Internalization of P(DMAEMAco-OEGMA) Gene Vectors. Successful gene transfer into eukaryotic cells and expression of the transferred pDNA is the result of a multistep process, including (i) complex formation, (ii) cell surface binding and internalization, (iii) intracellular trafficking and transfer into the cell nucleus, and (iv) transcription and translation of the transferred pDNA. 13 Characterization of P(DMAEMA-co-OEGMA) gene vectors indicated that pDNA condensation, surface charge, and transfection efficiency were largely dependent on OEGMA copolymerization, but cytotoxicity and particle size were less affected by OEGMA copolymerization. Although P(DMAEMA-co-OEGMA) copolymers mediated cell transfection and gene expression, their performances were below those of br-PEI 25 kDa. To better understand and overcome the limitations of P(DMAEMA-co-OEGMA) copolymer-based gene vectors, a detailed investigation of their cell binding and internalization was performed. Furthermore, we wanted to clarify whether there was a direct correlation between transfection activity and cellular gene vector uptake. From earlier studies it was expected that both parameters decrease with increasing OEGMA copolymerization. 28, 61 In contrast, Petersen and co-workers suggested that high PEG ratios for PEI-g-PEG copolymers may lead to enhanced cellular uptake and, thus, enhanced transfection levels. 23 The critical question, however, was to assess to what extent cellular uptake of P(DMAEMA-co-OEGMA) gene vectors might be affected by F OEGMA . For this purpose, the influence of F OEGMA on cellular gene vector binding and internalization was investigated using flow cytometry (FACS).
The results of fluorescence quenching method (FQ) and cell scrub buffer method (CSB) are given in Figure 5A ,B. The percentage of cell population showing cellular fluorescence (% TOTO-1 positive cells) decreased with increasing F OEGMA and OEGMA molecular weight, whereby a drastic 100-fold decrease was observed for F OEGMA ) 33-42% and a value of OEGMA EG units of 9-23. This observation is likely a result of shielded positive surface gene vector charge, which reduces cell surface binding of P(DMAEMA-co-OEGMA) gene vectors compared to nonshielded P(DMAEMA) gene vectors. However, the mean fluorescence intensity of each of the cells decreased only 2-3-fold, indicating that the amount of internalized gene vector complexes per TOTO-1 positive cell was less affected by OEGMA-copolymerization compared to cell surface binding. These findings suggest that the initial step of cell surface binding is strongly inhibited by OEGMA-copolymerization. These observations confirm the importance of slightly positive zeta potential for gene vector complexes to be efficiently internalized into cells and are in agreement with previous studies. 18 However, the results with P(DMAEMA-co-OEGMA) gene vectors at optimized conditions for transfection with F OEGMA < 41% and OEGMA EG units < 23 revealed that cellular uptake was comparable with br-PEI (Trypan blue: 67.1 ( 3.7 TOTO-1 positive cells; MFI 5374 ( 789) although transfection efficiency was >10-fold lower. Therefore, the present data suggest that lower transfection activity of the P(DMAEMA-co-OEGMA) gene vectors may not just account for low cellular uptake but additional subsequent processes after cellular internalization may affect gene transfer efficiency and be less efficient for P(D-MAEMA-co-OEGMA) gene vectors than for PEI gene vectors. Among these, endolysosomal escape has been previously described to be critical for nonviral gene vectors in terms of their gene transfer efficiency. In particular, PEI gene vectors have been demonstrated to overcome this barrier very efficiently due to their high buffering capacity in the pH range of acidified endosomes which leads to the so-called "proton sponge effect" and successful endosomal release. Indeed, it may be conceivable that the buffering capacity of P(DMAEMA-co-OEGMA) copolymers is lower compared to PEI and, thus, represents the critical limitation for high transfection efficiency. Further studies are needed to address this issue in more detail. Moreover, it is likely that the inability of the P(DMAEMA-co-OEGMA) copolymers to condense pDNA as efficiently as PEI leads to immediate pDNA release upon cellular uptake accompanied by early onset of pDNA degradation and, thus, lower transfection efficiency. Further studies will be necessary to investigate the intracellular fate of P(DMAEMA-co-OEGMA) gene vectors upon cellular uptake in future in order to elucidate the critical step of the transfection process.
In Vivo Application. In a next step, we investigated gene transfer efficiency of P(DMAEMA-co-OEGMA) in the lungs of Balb/c mice. We used the MicoSprayer Aerolizer, which has been previously used for drug delivery to the smaller airways. 46 Whereas only low luciferase activity was observed in mice that were treated with PEI gene vectors, a strong signal for lucifrease activity was evident in mice treated with P[DMAEMA 80 -co-OEGMA (9) 40 ] (EG units ) 9 and F OEGMA ) 33.3%) gene vectors ( Figure 6A,B) . After 24 h, 7-fold higher transfection efficiency could be observed for P(DMAEMA-co-OEGMA) gene vectors in lung homogenates compared to the control group brPEI in vivo. In contrast to PEI-pDNA particles that showed rather large diameters of 202 ( 2 nm, P[DMAEMA 80 -co- OEGMA (9) 40 ] gene vectors were small, 106 ( 2 nm, under these conditions. These observations suggest that the size of the gene vector particles has a distinct effect on the in vivo gene transfer efficiency. However, in this context, it has to be considered that gene vectors were generated in saline. It has been previously suggested that using PEI mediated gene delivery is increased when water for injection is used for formulation compared to saline because of transient induction of a "hypoosmotic shock" which may facilitate intracellular gene vector uptake. 62 Therefore, PEI-mediated gene expression might be lower in our experiments compared with optimized conditions using water for injection. It is therefore even more promising that P[DMAEMA 80 -co-OEGMA (9) 40 ] gene vectors resulted in pronounced gene expression in the lungs using saline as more tolerable solvent than water for injection. However, additional effects such as adsorption of components of the bronchoalveolar lavage fluid to the particle surface may be important which have to be addressed in more detail in future studies. Furthermore, future studies will allow the assessment of their relevance in context with therapeutic application in mouse models of human lung diseases.
In summary, the in vivo results underline that PEGylation of cationic polymers can enhance colloidal stability under conditions which are required for in vivo application (high salt and pDNA concentrations) and, therefore, improve gene transfer to the lung.
Conclusion
Copolymerisation of oligo(ethylene glycol) methyl ether methacrylate (OEGMA) and N,N-dimethylaminoethyl methacrylate (DMAEMA) by atom transfer radical polymerization (ATRP) resulted in a series of well-defined P(DMAEMA-co-OEGMA) copolymers with different molecular structures, which were capable of condensing pDNA into gene vector particles of nanometer size. Increase of the molar OEGMA ratio and OEGMA chain length correlated inversely with gene vector characteristics such as size, morphology, and zeta potential, thereby allowing to form tailor-made gene vector complexes. In contrast to P(DMAEMA) and PEI gene vectors, P(D-MAEMA-co-OEGMA) copolymers prevented gene vector aggregation at high concentrations in isotonic saline and did not induce cytotoxicity even at high concentrations. Whereas transfection efficiency of most efficient P(DMAEMA-co-OEGMA) copolymers was found to be >10-fold lower compared with br-PEI 25 kDa, this discrepancy does not simply appear to represent the exclusive cause of the reduced cellular uptake of the P(DMAEMA-co-OEGMA) copolymer gene vectors. Although OEGMA copolymerisation reduced gene vector binding with the cell surface at high F OEGMA , this was not observed for low F OEGMA . These observations suggest that inefficient endolysosomal escape and pDNA condensation may affect their transfection efficiency. In conclusion, structural tailoring of multiblock copolymers via ATRP provides a unique and versatile method to design gene transfer agents with excellent colloidal stability and low cytotoxicity and therefore meet the requirements for in vivo application. We could demonstrate that these particles are stable even under high salt and pDNA concentration and as a result showed improved gene expression in the lungs compared to the gold standard brPEI after intratracheal application. Improving intracellular uptake, cell specificity and intracellular trafficking of the P(DMAEMAco-OEGMA) copolymers gene vector complexes by using targeting ligands together with endolysosomal disrupting peptides may be an approach to further improve their transfection efficiency. Figure 6 . In vivo bioluminescence images of Balb/c mice (A) and luciferase expression in the lungs (B) after intratracheal application of 12.5 µg pCpGLuc. Gene vector complexes were prepared in HBS at N/P ratio of 20 and 10 using P(DMAEMA 80 -co-OEGMA(9) 40 ) polymer and brPEI 25 kDa, respectively. For luciferase expression, the lung region was selected and background subtraction applied by selecting an appropriate background on the same mouse. Results are given as photons per sec in mean ( standard deviation.
